Kwong, Lawrence N <br/><br/>
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma.  [electronic resource] 

 -  The Journal of clinical investigation  Apr 2015 
 - 1459-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1558-8238 
<br/><br/><label>Standard No.: </label>10.1172/JCI78954  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Doxycycline--pharmacology<br/>Drug Resistance, Neoplasm<br/>Gene Expression Profiling<br/>Humans<br/>Imidazoles--pharmacology<br/>Melanoma--drug therapy<br/>Melanoma, Experimental--drug therapy<br/>Mice<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Oximes--pharmacology<br/>PTEN Phosphohydrolase--physiology<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins B-raf--antagonists & inhibitors<br/>Tamoxifen--pharmacology<br/>Transgenes